Wellington Management Group’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,910,170
| Closed | -$144M | – | 2225 |
|
|
2022
Q2 | $144M | Sell |
1,910,170
-2,120,821
| -53% | -$160M | 0.03% | 456 |
|
|
2022
Q1 | $108M | Buy |
4,030,991
+21,337
| +0.5% | +$573K | 0.02% | 566 |
|
|
2021
Q4 | $191M | Buy |
4,009,654
+602,179
| +18% | +$28.7M | 0.03% | 454 |
|
|
2021
Q3 | $226M | Sell |
3,407,475
-42,334
| -1% | -$2.81M | 0.04% | 413 |
|
|
2021
Q2 | $269M | Buy |
3,449,809
+1,347,965
| +64% | +$105M | 0.04% | 377 |
|
|
2021
Q1 | $199M | Sell |
2,101,844
-131,901
| -6% | -$12.5M | 0.04% | 428 |
|
|
2020
Q4 | $272M | Buy |
2,233,745
+22,174
| +1% | +$2.7M | 0.05% | 337 |
|
|
2020
Q3 | $193M | Sell |
2,211,571
-72,301
| -3% | -$6.32M | 0.04% | 369 |
|
|
2020
Q2 | $148M | Buy |
2,283,872
+733,857
| +47% | +$47.4M | 0.03% | 426 |
|
|
2020
Q1 | $69.2M | Buy |
+1,550,015
| New | +$69.2M | 0.02% | 542 |
|